Skip to main content
Sanofi logo

Sanofi — Investor Relations & Filings

Ticker · SAN ISIN · FR0000120578 LEI · 549300E9PC51EN656011 PA Manufacturing
Open in API
Filings indexed 4,405 across all filing types
Latest filing 2026-03-18 Regulatory Filings
Country FR France
Listing PA SAN

About Sanofi

https://www.sanofi.com/en/directory/

Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.

Recent filings

Filing Released Lang Actions
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
Regulatory Filings Classification · 95% confidence The document is a press release issued by Sanofi announcing that the FDA has granted 'Breakthrough Therapy designation' to their investigational drug venglustat. It details the clinical study results (LEAP2MONO) and regulatory status of the drug. As this is a general corporate announcement regarding regulatory milestones and product development that does not fit into specific financial reporting categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2026-03-18 English
Sanofi : Déclaration des transactions sur actions propres
Transaction in Own Shares Classification · 100% confidence The document is titled 'Déclaration des transactions sur actions propres' (Declaration of transactions on own shares) and provides a detailed table of share repurchase transactions conducted by Sanofi over a specific period (March 2020). This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of companies buying back their own shares.
2026-03-16 English
Sanofi: Disclosure of trading in own shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Disclosures of trading in own shares' and explicitly states it is pursuant to law on share repurchases, detailing specific purchases of its own shares by Sanofi over a defined period. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2026-03-16 English
Sanofi: Informations relatives au nombre de droits de vote et d'actions - FEVRIER 2026
Regulatory Filings Classification · 95% confidence The document is a formal notification regarding the total number of voting rights and shares, as required by Article L. 233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulation. This is a standard regulatory disclosure of share capital structure and voting rights, which does not fit into specific categories like 'Major Shareholding Notification' (which concerns specific investors) or 'Share Issue' (which concerns changes in capital). Given it is a mandatory regulatory disclosure of share structure, it falls under the general regulatory filing category.
2026-03-12 French
Sanofi: Information concerning the total number of voting rights and shares - February 2026
Regulatory Filings Classification · 95% confidence The document provides a periodic update on the total number of shares and voting rights for Sanofi, as required by French regulatory articles (L. 233-8 II of the Code de commerce). This type of disclosure is a standard regulatory requirement for listed companies to inform the market of their share capital structure and voting rights. Since it does not report a specific shareholder vote result (DVA), a major shareholding change (MRQ), or a share buyback (POS), it falls under the general category of regulatory filings.
2026-03-12 English
Sanofi : Déclaration des transactions sur actions propres
Transaction in Own Shares Classification · 100% confidence The document is titled 'Déclaration des transactions sur actions propres' (Declaration of transactions on own shares) and provides a detailed table of share repurchase transactions conducted by Sanofi over a specific period. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2026-03-09 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.